Lisa Adler

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy et al. · Gynecologic Oncology · 2009 · 298 citations · Full text

Medicine, Gynecology, Oncology +8

Expression of αvβ3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas

Helen Liapis, Lisa Adler, Mark R. Wick et al. · Human Pathology · 1997 · 100 citations

Medicine, Cell Biology, Oncology +10

Elevated Cytotoxicity in Combat Veterans with Long-Term Post-traumatic Stress Disorder: Preliminary Observations

Mark L. Laudenslager, R. Aasal, Lisa Adler et al. · Brain Behavior and Immunity · 1998 · 82 citations

Medicine, Psychiatry, Toxicology +11

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Paula M. Fracasso, John A. Blessing, Kelly L. Molpus et al. · Gynecologic Oncology · 2006 · 62 citations

Medicine, Gynecology, Oncology +13

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study

Paul Sabbatini, Michael W. Sill, David M. O’Malley et al. · Gynecologic Oncology · 2008 · 49 citations

Medicine, Gynecology, Oncology +17